Forgot Password?
Return to Course Listing

CME: Charting the course to best practice in the recognition and management of amyotrophic lateral sclerosis (ALS)

Activity Description / Statement of Need:

In this online, self-learning activity:

Amyotrophic lateral sclerosis (ALS), characterized by loss of motor neurons in the cortex and spinal cord and progressive paralysis. A quarter of patients survive no more than six months after symptom onset or diagnosis, and the majority of patients die from respiratory failure within 5 years. Although the etiology of ALS remains unknown, evidence suggests autoimmune mechanisms, genetic mutations, and environmental factors play roles. Occurring more commonly in men, the incidence of ALS varies widely and is estimated to be between 1 and 23 per 100,000 person-years, and the prevalence 6 to 9. Estimates of the economic burden range from $64,000 to $200,000 per patient per year.

Target Audience:

The following HCPs: neurologists, physician assistants, nurse practitioners, and pharmacists who specialize in neurology; and those who otherwise commonly care for or clinically encounter patients with ALS.

Commercial Support Disclosure: This program is supported by an educational grant from Mitsubishi Tanabe.

This activity is free of charge.

Release Date: February 06, 2024 -- Expiration Date: February 06, 2026

Faculty: Jeffrey A. Mullen, MD


Faculty introduction, disclosures

Introductory content

·        Epidemiology

·        Pathophysiology, clinical features, risk factors, biomarkers, and diagnosis (including differential diagnosis)

  • Health burden

Managing amyotrophic lateral sclerosis 

  • Goals of therapy
  • Current and emerging therapies, including:

·        Glutamatergic inhibition

·        Free radical-directed therapy

·        Histone deacetylase inhibition

·        Antisense oligonucleotide therapy

·        Role and importance of supportive therapies: respiratory, nutrition, musculoskeletal, pain-related, and psychological

  • Considerations in providing optimal patient care: improving patient medication access, importance of an interdisciplinary approach in ALS 
  • Future of ALS: investigational therapies
  • Best practice: putting it all together
  • Patient case(s) 

Summary, conclusions, and best practice recap

Learning Objectives

By the end of the session the participant will be able to:

  • Summarize the healthcare burden unique to patients with ALS and challenges to optimal identification and management.
  • Identify current and emerging treatment strategies and their present or anticipated places in therapy for ALS.
  • Formulate a treatment plan for a patient with ALS.


ACCME Activity #202607834

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.


ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABIM MOC Credit Type: Medical Knowledge

Physicians: For maintenance of certification (MOC) points, you must enter your board certification ID # and birth date correctly.  It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC points for this activity. By providing this data, you acknowledge that it will be shared with ACCME and the applicable certifying board. Please note: Not all activities on this site provide MOC points. If this activity does not specify that it provides MOC points in this section, then it does NOT provide MOC points. This activity provides MOC points only for ABIM.


ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE #0574-0000-24-001-H01-P. This is an Application (A)-type activity. 

PharmacistsYou must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.

Nurses: The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™.

Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit™ assigned by organizations accredited by the ACCME as satisfying Category 1 CME for National Commission on Certification of Physician Assistants (NCCPA) national certification maintenance. This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCB) states that continuing education providers accredited by the ACCME may provide acceptable, accredited Advanced Practice Provider content. This activity is designated for up to 1.0 AMA PRA Category 1 Credit(s)™.

Faculty Disclosure and Resolution of COI

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.

Disclosures of Faculty: Jeffrey A. Mullen, MD, Assistant Professor, Department of Neurology, UCI School of Medicine, has no relevant financial disclosures.

Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures.

Faculty WILL NOT discuss off-label uses of a commercial product.

All relevant financial relationships have been mitigated.

ScientiaCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Commercial Support Disclosure: This program is supported by an educational grant from Mitsubishi Tanabe.


  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

System Requirements

Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.

Additional Courses That Are Related To This Activity

Transthyretin-mediated amyloidosis (ATTR): successful identification and its role in optimizing outcomes

Straightening out our approach to the management of cervical dystonia: optimizing treatment strategies

Waking to our potential in the management of narcolepsy and excessive daytime sleepiness: Treatment updates and gaps in care

Contemporary challenges and updates and in the diagnosis and management of Alzheimer’s disease – from early disease onward